Scandinavian Medical Solutions A/S OMXCOP:SMSMED:
OPERATING PROFIT (EBITDA) FELL BY 50% TO DKK 11M IN 2024/25 (2023/24: DKK 21M)
REVENUE INCREASED BY 8% TO DKK 245 MILLION IN 2024/25 (2023/24: DKK 227 MILLION)
Scandinavian Medical Solutions FY EBITDA Falls To DKK 11 Mln
Scandinavian Medical Solutions A/S on 6ix
Earlier from Scandinavian Medical Solutions
- Scandinavian Medical Solutions A/S: Quarterly Trading Report 2025 Q3
- Scandinavian Medical Solutions Sells Siemens PET/CT Scanner
- SMSMED: Revenue up 20% but margins and earnings pressured by market volatility and U.S. expansion
- SMSMED: Guidance cut amid tariff and currency risks, but US presence and cost controls support resilience
- SMSMED: Revenue and EBITDA hit targets, with full rental fleet utilization and U.S. expansion boosting growth.
Later from Scandinavian Medical Solutions
- Scandinavian Medical Solutions A/S - increase
- SMS Secures Major Sales in the First Part of the 2025/26 Financial Year
- Customer In East Europe Buys PET/MR System From SMS
- Scandinavian Medical Solutions Sells MRI Scanner To American Market
- Scandinavian Medical Solutions Sells MRI-Scanner To New Partner In South Europe
Follow Scandinavian Medical Solutions into a list and get an email when it puts out news.
Follow Scandinavian Medical Solutions